ImmunityBio, Inc. (IBRX)
8.39
+0.57
(+7.29%)
USD |
NASDAQ |
Mar 13, 16:00
8.58
+0.19
(+2.26%)
After-Hours: 04:10
ImmunityBio EPS Diluted (Quarterly) : -0.0626 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Krystal Biotech, Inc. | 1.699 |
| Arcellx, Inc. | -1.003 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.96M |
| Revenue (Quarterly) | 38.28M |
| Total Expenses (Quarterly) | 100.23M |
| Enterprise Value | 9.229B |
| Gross Profit Margin (Quarterly) | 88.91% |
| Profit Margin (Quarterly) | -161.8% |
| Earnings Yield | -4.65% |
| Normalized Earnings Yield | -4.715 |